OB:MEDIMedical Equipment
Medistim (OB:MEDI) Margins Reach 20.9%, Reinforcing Profit Growth Narrative
Medistim (OB:MEDI) reported ongoing momentum in both revenue and earnings, with annual earnings growth forecast at 8.55% and revenue anticipated to rise by 7.5% per year. Net profit margins were up to 20.9%, compared to 19.6% a year ago, and recent earnings growth hit 25.7%, comfortably above the five-year average of 10% per year. Investors are likely to see these results as signs of operational strength, even as share price stability has been lacking over the past three months and valuation...